We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Novel Polymer Destroys Eosinophils and Reduces the Inflammatory Response

By LabMedica International staff writers
Posted on 08 Dec 2009
Allergy specialists have found that a synthetic polysaccharide could mimic the action of a monoclonal antibody and bind to an eosinophil surface lectin (sugar binding protein) in a fashion that triggered death of the cells with a subsequent reduction in overall immune inflammatory activity.

The lectin Siglec-8 (sialic acid-binding, immunoglobulin-like lectin), which is selectively expressed on eosinophil surfaces and regulates eosinophil survival, preferentially binds to the glycan 6′-sulfo-sialyl Lewis X (6′-sulfo-sLe X). More...
Sialyl Lewis X, also known as sialyl Le X and SLe X, is a tetrasaccharide carbohydrate that is usually attached to O-glycans on the surface of certain granulocytes and is known to play a vital role in cell-cell recognition processes. Sialyl Lewis X is one of the most important blood group antigens and is displayed on the terminus of glycolipids that are present on the cell-surface.
Investigators at Johns Hopkins University (Baltimore, MD, USA) prepared a soluble synthetic polymer displaying 6′-sulfo-sLe X glycan. They found that this polymer selectively bound to human eosinophils and human embryonic kidney 293 cells expressing Siglec-8. Binding was inhibited by anti-Siglec-8 antibody. In whole blood, eosinophils were the only leukocyte subtype to bind the polymer.

Further results published in the August 2009 issue of the Journal of Pharmacology and Experimental Therapeutics revealed that when working with pure cultures of eosinophils, the polymer killed about 65% of the eosinophils in about 72 hours. It was, however, not as effective as a specific monoclonal antibody, which killed up to 90% of the cells in 24 hours.

"This is initial proof that delivering the sugar through a polymer can give you the desired result of selectively engaging Siglec-8 and killing eosinophils, but we still have a long way to go,” said senior author Dr. Bruce S. Bochner, professor of allergy and clinical immunology at Johns Hopkins University. "The trick is that you need to engage several clusters of Siglec-8 on each cell at once to trigger cell death. You are not going to be able to do that with individual sugar molecules in solution.”

Related Links:

Johns Hopkins University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Pipette Calibration System
Artel PCS®
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.